Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -90.00% | 0.00% | 0.00% |
2015 | MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2014 | MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application | CI |
Business Summary
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | 0.00% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | 0.00% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,448 | 0 | 0 | 90.01 % |
Stock B | 1 | 5,000,948,700 | 4,501,353,925 ( 90.01 %) | 0 |
Company contact information
MultiCell Technologies, Inc.
4144 North Central Expressway Suite 600
75204, Dallas
+
Sector
1st Jan change | Capi. | |
---|---|---|
0.00% | 5K | |
+19.18% | 47.02B | |
+48.77% | 41.86B | |
+0.21% | 41.76B | |
-4.27% | 28.8B | |
+11.80% | 26.05B | |
-22.10% | 19.15B | |
+4.09% | 12.55B | |
+29.25% | 12.34B | |
-3.98% | 11.82B |
- Stock Market
- Equities
- MCET Stock
- Company MultiCell Technologies, Inc.